Riskpilot← Back to searchSign inGet full accessVaxholms Vårdcentral AB
ABActiveOrg 5567455919Kapellgatan 2General medical practice activities · NACE 8621Est. 200726 employees
Revenue 2024
SEK 31,9M
+2% vs 2023
EBITDA margin
15.2%
-32% vs 2023
Equity ratio
35.9%
Financial strength
Net profit 2024
SEK 92K
+61% vs 2023
| Revenue | SEK 31,9M | +2% |
| EBITDA | SEK 4,9M | -32% |
| Net profit | SEK 92K | +61% |
| Total assets | SEK 19,6M | +2% |
| Equity | SEK 7M | +1% |
| Employees | 26 | — |
Legal name
Vaxholms Vårdcentral AB
Org number
5567455919
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 december 2007
Share capital
SEK 200 000
Employees
26 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva allmänmedicinsk och annan sjuk- och hälsovårdsanknuten verksamhet samt undervisning inom samma områden ävensom idka annan därmed förenlig verksamhet.
Address
Kapellgatan 2
Phone
+46854171800
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 26 789 | 30 160 | 32 202 | 31 389 | 31 865 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 671 | 1 754 | 1 539 | 7 154 | 4 852 |
| Depreciation & amort. | −43 | −39 | −30 | −30 | −16 |
| EBIT | 1 628 | 1 715 | 1 509 | 7 124 | 4 836 |
| Net financials | −16 | −6 | −8 | −50 | −802 |
| Profit before tax | 1 612 | 9 | 15 | 85 | 330 |
| Tax | −348 | −9 | −5 | −28 | −238 |
| Net profit | 1 264 | 0 | 10 | 57 | 92 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 168 | 12 978 | 13 990 | 19 227 | 19 640 |
| Equity | 6 889 | 6 890 | 6 900 | 6 957 | 7 049 |
| Long-term debt | 0 | 0 | 0 | 8 072 | 8 877 |
| Short-term debt | 3 279 | 6 089 | 7 092 | 4 211 | 3 722 |
| Total debt | 3 279 | 6 089 | 7 092 | 12 283 | 12 599 |
EBITDA margin
15.2%
This company
15.8%
Market median
+4% vs market
20202024
Equity ratio
35.9%
This company
38.2%
Market median
+6% vs market
20202024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
1.62×
This company
1.12×
Market median
+45% vs market
20202024
Debt / equity
1.79×
This company
0.62×
Market median
-189% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SE Chief Executive Officer | Chief Executive Officer | 2022 |
MS Audit | Audit | 2025 |
AM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Familjeläkarna i Saltsjöbaden AB
Vaxholms Vårdcentral AB Board members of Vaxholms Vårdcentral AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Erik Ingvar Amér | Chief Executive Officer | 0 companies |
| Mikael Stefan Köver | Audit | 0 companies |
| Anna Maria Cecilia Amér | Deputy Chief Executive Officer | 0 companies |